New Key Statistics Module, Z-Score and F-Score
OTCPK:VPHIF Key Ratios
| Market Cap $ M | 4.73 |
| Enterprise Value $ M | 49.45 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.11 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 40.00 |
| EPS (TTM) $ | -0.24 |
| Beneish M-Score | -5.86 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -33.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.50 |
| EV-to-EBITDA | -5.48 |
| PEG | -- |
| Shares Outstanding M | 98.66 |
| Net Margin (%) | -54.26 |
| Operating Margin % | -34.51 |
| Pre-tax Margin (%) | -54.26 |
| Quick Ratio | 0.27 |
| Current Ratio | 0.40 |
| ROA % (ttm) | -70.86 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -55.46 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.76 |
VPHIF Number of Guru Trades
VPHIF Volume of Guru Trades
Gurus Latest Trades with OTCPK:VPHIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:VPHIF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Valeo Pharma Inc Insider Transactions
No Available Data
News about OTCPK:VPHIF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers